{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:21:12Z","timestamp":1790680872510,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL 1TR002541"],"award-info":[{"award-number":["UL 1TR002541"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jid.2021.02.741","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T01:05:11Z","timestamp":1616547911000},"page":"2161-2169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Differential Molecular Expression Patterns Associated with Metastasis in Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3796-7146","authenticated-orcid":false,"given":"Patrick M.","family":"Mulvaney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5114-2613","authenticated-orcid":false,"given":"Paul R.","family":"Massey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-5566","authenticated-orcid":false,"given":"Kenneth K.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4413-8848","authenticated-orcid":false,"given":"Jack E.","family":"Drinan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0446-5847","authenticated-orcid":false,"given":"Chryslayne D.","family":"Schmults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.02.741_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.oooo.2014.12.019","article-title":"MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas","volume":"119","author":"Ahmed Haji Omar","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.jid.2021.02.741_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0194599818788057","article-title":"PD-L1 expression and tumor-infiltrating lymphocytes in high-risk and metastatic cutaneous squamous cell carcinoma","volume":"160","author":"Amoils","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jid.2021.02.741_bib3","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/hed.24765","article-title":"Reviewing the genetic alterations in high-risk cutaneous squamous cell carcinoma: a search for prognostic markers and therapeutic targets","volume":"39","author":"Ashford","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.jid.2021.02.741_bib4","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/hed.23188","article-title":"p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck","volume":"35","author":"Beadle","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/j.jid.2021.02.741_bib5","first-page":"48","article-title":"Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update","volume":"2","author":"Bethune","year":"2010","journal-title":"J\u00a0Thorac Dis"},{"key":"10.1016\/j.jid.2021.02.741_bib6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1470-2045(08)70178-5","article-title":"Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study","volume":"9","author":"Brantsch","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2021.02.741_bib7","first-page":"1179","article-title":"Epidermal growth factor receptor expression is associated with poor outcome in cutaneous squamous cell carcinoma","volume":"176","author":"Ca\u00f1ueto","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjd.15236","article-title":"MicroRNA (miR)-203 and miR-205 expression patterns identify subgroups of prognosis in cutaneous squamous cell carcinoma","volume":"177","author":"Ca\u00f1ueto","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.humpath.2007.07.004","article-title":"Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma","volume":"39","author":"Ch\u2019ng","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jid.2021.02.741_bib10","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1038\/ncomms12048","article-title":"Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma","volume":"7","author":"Chahal","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.02.741_bib11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.oraloncology.2013.03.430","article-title":"MicroRNA-17\/20a functions to inhibit cell migration and can be used a prognostic marker in oral squamous cell carcinoma [published correction appears in Oral Oncol 2017;72:202\u201303]","volume":"49","author":"Chang","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jid.2021.02.741_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41419-019-1516-2","article-title":"USF1-induced upregulation of LINC01048 promotes cell proliferation and apoptosis in cutaneous squamous cell carcinoma by binding to TAF15 to transcriptionally activate YAP1","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jid.2021.02.741_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/bjd.13226","article-title":"Overexpression of p300 correlates with poor prognosis in patients with cutaneous squamous cell carcinoma","volume":"172","author":"Chen","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4161\/cbt.7.5.5768","article-title":"Nuclear Kr\u00fcppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis","volume":"7","author":"Chen","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jid.2021.02.741_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2019.05.077","article-title":"Programmed cell death 1 Protein and programmed death-ligand 1 inhibitors in the treatment of nonmelanoma skin cancer: a systematic review","volume":"82","author":"Choi","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaad.2018.10.018","article-title":"The prognostic value of inositol polyphosphate 5-phosphatase in cutaneous squamous cell carcinoma","volume":"80","author":"Cumsky","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000461578","article-title":"Efficacy and tolerance of cetuximab alone or combined with chemotherapy in locally advanced or metastatic cutaneous squamous cell carcinoma: an open study of 14 patients","volume":"232","author":"Dereure","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2021.02.741_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.02.741_bib19","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/abbs\/gmq026","article-title":"miR-20a promotes proliferation and invasion by targeting APP in human ovarian cancer cells","volume":"42","author":"Fan","year":"2010","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.jid.2021.02.741_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2017.11.004","article-title":"Identification of tissue damage, extracellular matrix remodeling and bacterial challenge as common mechanisms associated with high-risk cutaneous squamous cell carcinomas","volume":"66","author":"F\u00f6ll","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jid.2021.02.741_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/modpathol.3800066","article-title":"Metalloproteinase-2 expression correlates with aggressiveness of cutaneous squamous cell carcinomas","volume":"17","author":"Fundyler","year":"2004","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jid.2021.02.741_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/DAD.0000000000001164","article-title":"PD-L1 expression is increased in metastasizing squamous cell carcinomas and their metastases","volume":"40","author":"Garc\u00eda-D\u00edez","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jid.2021.02.741_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2017.05.047","article-title":"Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck","volume":"77","author":"Garc\u00eda-Pedrero","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/jdv.13098","article-title":"MicroRNA expression profiling in metastatic cutaneous squamous cell carcinoma","volume":"30","author":"Gillespie","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2021.02.741_bib25","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/cncr.31346","article-title":"Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: a single-arm phase 2 clinical trial","volume":"124","author":"Gold","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jid.2021.02.741_bib26","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1159\/000450920","article-title":"Characterisation of prognosis and invasion of cutaneous squamous cell carcinoma by podoplanin and E-cadherin expression","volume":"232","author":"Hesse","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2021.02.741_bib27","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/01.MP.0000032536.48264.D1","article-title":"Immunohistochemical comparison of p16 expression in actinic keratoses and squamous cell carcinomas of the skin","volume":"15","author":"Hodges","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jid.2021.02.741_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2230.2011.04275.x","article-title":"Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma","volume":"37","author":"Huang","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamadermatol.2013.2456","article-title":"Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system","volume":"149","author":"Jambusaria-Pahlajani","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0190-9622(99)70185-4","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"40","author":"Jensen","year":"1999","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/cei.12921","article-title":"Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells","volume":"188","author":"Jiao","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jid.2021.02.741_bib32","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/ajco.13102","article-title":"Association between PD-L1 expression and lymph node metastasis in cutaneous squamous cell carcinoma","volume":"16","author":"Kamiya","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.jid.2021.02.741_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5021\/ad.2009.21.4.382","article-title":"The expression of NMDA receptor 1 correlates with clinicopathological parameters in cutaneous squamous cell carcinoma","volume":"21","author":"Kang","year":"2009","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317698361","article-title":"Bioinformatics prediction and experimental validation of microRNA-20a targeting cyclin D1 in hepatocellular carcinoma","volume":"39","author":"Karimkhanloo","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jid.2021.02.741_bib35","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1111\/jdv.14845","article-title":"Cytokeratin 19 expression is a risk factor for metastasis in cutaneous squamous cell carcinoma","volume":"32","author":"Kato","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2021.02.741_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/0194599816641913","article-title":"Biomarker and pathologic predictors of cutaneous squamous cell carcinoma aggressiveness","volume":"155","author":"Khandelwal","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jid.2021.02.741_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jso.23238","article-title":"Podoplanin expression in cutaneous head and neck squamous cell carcinoma--prognostic value and clinicopathologic implications","volume":"107","author":"Kreppel","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jid.2021.02.741_bib38","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1158\/1078-0432.CCR-04-2274","article-title":"WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in\u00a0vivo","volume":"11","author":"Lai","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jid.2021.02.741_bib39","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1365-4632.2012.05525.x","article-title":"Expression of Fas and Fas ligand in primary cutaneous squamous cell carcinoma in association with grade of tumor differentiation","volume":"52","author":"Lee","year":"2013","journal-title":"Int J Dermatol"},{"issue":"Suppl. 8","key":"10.1016\/j.jid.2021.02.741_bib40","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jdv.15992","article-title":"Identification of responders to immune checkpoint therapy: which biomarkers have the highest value?","volume":"33","author":"Liebl","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2021.02.741_bib41","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.02.741_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164742","article-title":"Silencing of ASC in cutaneous squamous cell carcinoma","volume":"11","author":"Meier","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2021.02.741_bib43","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1470-2045(19)30728-4","article-title":"Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial","volume":"21","author":"Migden","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jid.2021.02.741_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1805131","article-title":"PD-1 blockade with Cemiplimab in advanced cutaneous squamous-cell carcinoma","volume":"379","author":"Migden","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.02.741_bib45","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jid.2021.02.741_bib46","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hed.25556","article-title":"Correlation of focal adhesion kinase expression with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma","volume":"41","author":"Mungu\u00eda-Calzada","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.jid.2021.02.741_bib73","series-title":"CSCC metastasis protein predictors, Mendeley Data, V1","author":"[dataset] Mulvaney","year":"2020"},{"key":"10.1016\/j.jid.2021.02.741_bib47","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jid.2021.02.741_bib48","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012","volume":"151","author":"Rogers","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jdermsci.2010.10.005","article-title":"Raf kinase inhibitor protein expression correlates with differentiation but not with ERK phosphorylation in cutaneous squamous cell carcinoma","volume":"60","author":"Rokunohe","year":"2010","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2021.02.741_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.pathol.2017.04.004","article-title":"PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma","volume":"49","author":"Roper","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.jid.2021.02.741_bib51","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.cellbi.2007.06.006","article-title":"Significance of eIF4E expression in skin squamous cell carcinoma","volume":"31","author":"Salehi","year":"2007","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jid.2021.02.741_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00403-019-01916-x","article-title":"Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma","volume":"311","author":"Santos-Juanes","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2021.02.741_bib53","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.pathol.2017.04.002","article-title":"p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis","volume":"49","author":"Satgunaseelan","year":"2017","journal-title":"Pathology"},{"key":"10.1016\/j.jid.2021.02.741_bib54","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/bjd.14955","article-title":"The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma","volume":"176","author":"Schaper","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jamadermatol.2013.2139","article-title":"Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study","volume":"149","author":"Schmults","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib56","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cup.12728","article-title":"PD-L1 expression in cutaneous squamous cell carcinoma correlates with risk of metastasis","volume":"43","author":"Slater","year":"2016","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2021.02.741_bib57","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1038\/jid.2014.154","article-title":"NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis","volume":"134","author":"South","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1346-8138.2005.tb00906.x","article-title":"Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma","volume":"32","author":"Suiqing","year":"2005","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib59","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1600-0560.2012.01912.x","article-title":"CD147 expression in advanced cutaneous squamous cell carcinoma","volume":"39","author":"Sweeny","year":"2012","journal-title":"J\u00a0Cutan Pathol"},{"key":"10.1016\/j.jid.2021.02.741_bib60","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/hed.21802","article-title":"EGFR expression in advanced head and neck cutaneous squamous cell carcinoma","volume":"34","author":"Sweeny","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.jid.2021.02.741_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00042728-200504000-00008","article-title":"LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases","volume":"31","author":"Tanemura","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jid.2021.02.741_bib62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.canlet.2017.11.014","article-title":"Progress and challenges of predictive biomarkers of anti PD-1\/PD-L1 immunotherapy: a systematic review","volume":"414","author":"Teng","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jid.2021.02.741_bib63","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jaad.2012.03.007","article-title":"D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: a marker of metastatic risk","volume":"67","author":"Toll","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2013.07.001","article-title":"Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases","volume":"72","author":"Toll","year":"2013","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2021.02.741_bib65","first-page":"370","article-title":"Podoplanin - a small glycoprotein with many faces","volume":"6","author":"Ugorski","year":"2016","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jid.2021.02.741_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.humpath.2016.10.018","article-title":"DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients","volume":"60","author":"Venza","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jid.2021.02.741_bib67","first-page":"420796","article-title":"Prognostic and risk factors in patients with locally advanced cutaneous squamous cell carcinoma of the trunk and extremities","volume":"2011","author":"Vinicius de","year":"2011","journal-title":"J\u00a0Skin Cancer"},{"key":"10.1016\/j.jid.2021.02.741_bib68","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1365-2230.2012.04365.x","article-title":"Overexpression of RNA helicase p68 protein in cutaneous squamous cell carcinoma","volume":"37","author":"Wang","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib69","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaad.2017.07.048","article-title":"Gefitinib for patients with incurable cutaneous squamous cell carcinoma: a single-arm phase II clinical trial","volume":"77","author":"William","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib70","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jamadermatol.2015.3781","article-title":"The expression status and prognostic value of cancer stem cell biomarker CD133 in cutaneous squamous cell carcinoma","volume":"152","author":"Xu","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2021.02.741_bib71","first-page":"11446","article-title":"Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jid.2021.02.741_bib72","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41467-018-07998-x","article-title":"Mir20a\/106a-WTX axis regulates RhoGDIa\/CDC42 signaling and colon cancer progression","volume":"10","author":"Zhu","year":"2019","journal-title":"Nat Commun"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21010034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21010034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:46:04Z","timestamp":1762206364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21010034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0022202X21010034"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.02.741","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Molecular Expression Patterns Associated with Metastasis in Cutaneous Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.02.741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}